Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 20/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL899069 | 1.00 | FDPS (0.41) | FDPS | |
| SCHEMBL7529028 | 1.00 | FDPS (0.41) | FDPS | |
| SCHEMBL1773792 | 0.97 | FDPS (0.41) | FDPS | |
| Phosphoric Acid SCHEMBL5449030 | 0.95 | FDPS (0.43) | FDPS | |
| SCHEMBL669819 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL6264031 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL4486157 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL4489691 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL28904337 | 0.94 | FDPS (0.43) | FDPS | |
| SCHEMBL28390378 | 0.94 | FDPS (0.43) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260047474-A1 | SEMICONDUCTOR PACKAGE AND METHOD OF MANUFACTURING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-02-12 | — | — | US | claimed |
| US-20260047474-A1 | SEMICONDUCTOR PACKAGE AND METHOD OF MANUFACTURING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-02-12 | — | — | US | disclosed |
| CN-117572697-A | Film, display panel, preparation method of display panel and display device | TCL华星光电技术有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-110560157-B | Alumina-supported ionic liquid-palladium-silver bimetallic catalyst and preparation method and application thereof | 浙江工业大学 | 2022-12-09 | — | — | CN | disclosed |
| CN-111621030-B | Preparation method of hierarchical porous metal organic framework material for drug loading sustained release | 华侨大学 | 2022-02-08 | — | — | CN | disclosed |
| CN-111971807-A | Thermoelectric conversion module | 琳得科株式会社 | 2020-11-20 | — | — | CN | disclosed |
| US-20200339577-A1 | 1-SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,7-NAPHTHYRIDIN-8-AMINE DERIVATIVES AND THEIR USE AS EP4 RECEPTOR ANTAGONISTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-10-29 | — | — | US | disclosed |
| CN-111621030-A | Preparation method of hierarchical porous metal organic framework material for drug loading sustained release | 华侨大学 | 2020-09-04 | — | — | CN | disclosed |
| US-10745397-B2 | 1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-08-18 | — | — | US | disclosed |
| EP-3300150-B1 | OXYGEN REDUCTION CATALYST, METHOD FOR PRODUCING THE SAME, AND POLYMER ELECTROLYTE FUEL CELL | SHOWA DENKO KK (JP) | 2020-02-19 | — | — | EP | disclosed |
| EP-2665118-A1 | METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND APPLICATION THEREOF | Showa Denko K.K. (JP) | 2013-11-20 | — | — | EP | disclosed |
| EP-2665119-A1 | METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND APPLICATION THEREOF | Showa Denko K.K. (JP) | 2013-11-20 | — | — | EP | disclosed |
| US-20130295483-A1 | METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND USES THEREOF | SHOWA DENKO K.K. (JP) | 2013-11-07 | — | — | US | disclosed |
| US-20130288154-A1 | METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND USES THEREOF | SHOWA DENKO K.K. (JP) | 2013-10-31 | — | — | US | disclosed |
| US-20130244867-A1 | CATALYST FOR PRODUCING N-SUBSTITUTED CARBAMATES, AND THE PREPARATION AND APPLICATION OF THE SAME | BAYER MATERIALSCIENCE AG | 2013-09-19 | — | — | US | disclosed |
| US-8513453-B2 | Process for preparing aromatic carbamates | BAYER MATERIALSCIENCE AG (DE) | 2013-08-20 | — | — | US | disclosed |
| US-8450516-B2 | Catalyst for producing N-substituted carbamates, and the preparation and application of the same | BAYER MATERIALSCIENCE AG (DE) | 2013-05-28 | — | — | US | disclosed |
| US-20120041223-A1 | PROCESS FOR PREPARING AROMATIC CARBAMATES | BAYER MATERIALSCIENCE AG (DE) | 2012-02-16 | — | — | US | disclosed |
| US-20100298592-A1 | CATALYST FOR PRODUCING N-SUBSTITUTED CARBAMATES, AND THE PREPARATION AND APPLICATION OF THE SAME | BAYER MATERIALSCIENCE AG (DE) | 2010-11-25 | — | — | US | disclosed |
| EP-2230228-A1 | Process for preparing aromatic carbamates | Bayer MaterialScience AG (DE) | 2010-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10745397-B2 | 1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists | PTGER4, PTGER1, PTGER3 | FDPS 4469/4885 |
| US-20200339577-A1 | 1-SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,7-NAPHTHYRIDIN-8-AMINE DERIVATIVES AND THEIR USE AS EP4 RECEPTOR ANTAGONISTS | PTGER4, PTGER1, PTGER3 | FDPS 4469/4885 |
| US-20120041223-A1 | PROCESS FOR PREPARING AROMATIC CARBAMATES | KAT6A, CA6, TYR | FDPS 2546/4885 |
| US-20260047474-A1 | SEMICONDUCTOR PACKAGE AND METHOD OF MANUFACTURING THE SAME | SELP, EPCAM, CDH1 | FDPS 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.